SPAGO NANOMEDICAL AB

Insiders Spago Nanomedical AB

Equities

SPAG

SE0004899474

Delayed Nasdaq Stockholm Other stock markets 03:00:03 2024-04-30 am EDT			5-day change	1st Jan Change
0.358 ^SEK	-0.56%		+23.45%	+9.48%

Apr. 24	Spago Nanomedical AB Reports Favorable Data in Breast Cancer Model with Tumorad	CI
Apr. 16	Spago Nanomedical AB Announces Appointment of Birgitta Rembratt Svensson as Head of CMC & Supply, Effective June 1, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spago Nanomedical AB Announces Appointment of Birgitta Rembratt Svensson as Head of CMC & Supply, Effective June 1, 2024	Apr. 16	CI
Spago Nanomedical AB Announces Establishment of A Scientific Advisory Board	23-06-13	CI
Spago Nanomedical AB Elects New Directors	23-05-10	CI
Spago Nanomedical AB Announces Board Resignations	23-04-05	CI
The nomination committee proposes changes to the board of Spago Nanomedical for increased commercial focus	23-04-04	AQ
Nomination committee appointed for the 2023 Annual General Meeting in Spago Nanomedical	22-10-20	AQ
Spago Nanomedical : Nomination committee appointed for the 2022 Annual General Meeting in Spago Nanomedical	21-10-21	AQ
Spago Nanomedical AB Appoints Paul Hargreaves as Chief Development Officer	21-08-03	CI
Spago Nanomedical AB Appoints Candidate Drug in the Tumorad® Project	20-08-24	CI
Spago Nanomedical Approves Appointment of Peter Wulff to its Board of Directors Replacing Jörgen Buus Lassen	16-04-19	CI
Spago Imaging AB Appoints Eva Redhe Ridderstad as Chairman of the Board	12-11-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer